Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
CHINOOK THERAPEUTICS, INC. (KDNY)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/02/2020 |
8-K
| Investor presentation, Acquisition/merger/asset purchase announced, Entered into consulting agreement|
Docs:
|
"FORM 8-K",
"Agreement and Plan of Merger and Reorganization, by and among Aduro Biotech, Inc., Aspire Merger Sub, Inc. and Chinook Therapeutics U.S., Inc",
"Note Purchase Agreement, by and among Chinook Therapeutics U.S., Inc. and certain investors named therein",
"Form of Convertible Promissory Note",
"Form of Support Agreement by and between Aduro Biotech, Inc. and certain stockholders of Chinook Therapeutics U.S., Inc",
"Form of Support Agreement by and between Chinook Therapeutics U.S., Inc. and certain stockholders of Aduro Biotech, Inc",
"Form of Lock-Up Agreement",
"Form of CVR Agreement",
"Consulting Agreement, by and between Aduro Biotech, Inc. and Andrea van Elsas, Ph.D",
"Aduro Biotech and Chinook Therapeutics Announce Definitive Merger Agreement",
"Investor Presentation" |
|
| 01/11/2016 |
8-K
| Investor presentation |
|
|